AV
TEVA icon

ASR Vermogensbeheer’s Teva Pharmaceuticals TEVA Stock Holding History

ASR Vermogensbeheer’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
57,395
+22,780
+66% +$759K 0.02% 363
2026
Q1 		$1.04M Buy
34,615
+2,700
+8% +$86.9K 0.01% 423
2025
Q4 		$996K Hold
31,915
– – 0.01% 436
2025
Q3 		$645K Buy
31,915
+515
+2% +$9.04K 0.01% 468
2025
Q2 		$526K Buy
31,400
+500
+2% +$8.07K 0.01% 485
2025
Q1 		$475K Buy
+30,900
New +$552K 0.01% 491

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

ASR Vermogensbeheer's TEVA Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Teva Pharmaceuticals (TEVA) stake by 66% in Q2 2026, buying an estimated $759K and bringing the position to 57,395 shares worth $1.94M. The position accounts for 0.02% of the portfolio, ranked #363.

ASR Vermogensbeheer first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • ASR Vermogensbeheer held 57,395 shares of Teva Pharmaceuticals worth $1.94M as of Q2 2026.
  • ASR Vermogensbeheer bought 22,780 Teva Pharmaceuticals shares in Q2 2026, an estimated $759K.
  • Teva Pharmaceuticals made up 0.02% of ASR Vermogensbeheer's portfolio in Q2 2026, its #363 holding.
  • ASR Vermogensbeheer first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.